Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0I9GR
|
||||
Former ID |
DCL000337
|
||||
Drug Name |
Plevitrexed
|
||||
Synonyms |
Plevitrexed [INN]; BGC9331; ZD 9331; ZD9331; ZD-9331; (2S)-2-((4-(((2,7-Dimethyl-4-oxo-1,4-dihydroquinazolin-6-yl)methyl)(prop-2-ynyl)amino)-2-fluorobenzoyl)amino)-4-(1H-tetrazol-5-yl)butanoic acid; (2S)-2-[[4-[(2,7-dimethyl-4-oxo-1H-quinazolin-6-yl)methyl-prop-2-ynylamino]-2-fluorobenzoyl]amino]-4-(2H-tetrazol-5-yl)butanoic acid; (2s)-2-[(2-fluoro-4-{[(4-hydroxy-2,7-dimethylquinazolin-6-yl)methyl](prop-2-yn-1-yl)amino}benzoyl)amino]-4-(2h-tetrazol-5-yl)butanoic acid
|
||||
Drug Type |
Small molecular drug
|
||||
Company |
BTG
|
||||
Structure |
Download2D MOL |
||||
Formula |
C26H25FN8O4
|
||||
InChI |
InChI=1S/C26H25FN8O4/c1-4-9-35(13-16-11-19-22(10-14(16)2)28-15(3)29-25(19)37)17-5-6-18(20(27)12-17)24(36)30-21(26(38)39)7-8-23-31-33-34-32-23/h1,5-6,10-12,21H,7-9,13H2,2-3H3,(H,30,36)(H,38,39)(H,28,29,37)(H,31,32,33,34)/t21-/m0/s1
|
||||
InChIKey |
IEJSCSAMMLUINT-NRFANRHFSA-N
|
||||
CAS Number |
CAS 153537-73-6
|
||||
PubChem Compound ID | |||||
PubChem Substance ID |
525044, 11438742, 14763215, 14763216, 14934453, 30417265, 50068467, 57399646, 76715527, 78907166, 103066645, 103080055, 103356879, 103981287, 113453116, 117622467, 128155971, 134338945, 134338991, 134340694, 134340698, 135187320, 137542816, 138647661, 162802588, 164232738, 164764471, 180371003, 198971042, 198979701, 224042541, 226538633, 235406768, 252166490
|
||||
Target and Pathway | |||||
Target(s) | Thymidylate synthase | Target Info | Inhibitor | [536356] | |
BioCyc Pathway | Pyrimidine deoxyribonucleotides biosynthesis from CTP | ||||
Pyrimidine deoxyribonucleotides de novo biosynthesis | |||||
Superpathway of pyrimidine deoxyribonucleotides de novo biosynthesis | |||||
Superpathway of pyrimidine deoxyribonucleoside salvage | |||||
DTMP de novo biosynthesis (mitochondrial) | |||||
Pyrimidine deoxyribonucleosides salvage | |||||
Pathway Interaction Database | E2F transcription factor network | ||||
PathWhiz Pathway | Pyrimidine Metabolism | ||||
WikiPathways | Trans-sulfuration and one carbon metabolism | ||||
Retinoblastoma (RB) in Cancer | |||||
One Carbon Metabolism | |||||
Integrated Pancreatic Cancer Pathway | |||||
miR-targeted genes in muscle cell - TarBase | |||||
miR-targeted genes in lymphocytes - TarBase | |||||
miR-targeted genes in leukocytes - TarBase | |||||
miR-targeted genes in epithelium - TarBase | |||||
Metabolism of nucleotides | |||||
Fluoropyrimidine Activity | |||||
References | |||||
Ref 532289 | Phase 2 study of pemetrexed and itraconazole as second-line therapy for metastatic nonsquamous non-small-cell lung cancer. J Thorac Oncol. 2013 May;8(5):619-23. | ||||
Ref 543033 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8278). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.